After J&J sale, Cambridge investor sets sights on $175M raise for new medtech VC firm

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 20, 2019 at 9:52 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,746
    Likes Received:
    3
    via What will the next life sciences unicorn be? If you ask venture capitalist Chris Velis’ son, it could come from his new Cambridge investment firm.

    “Dad, I get it. You don’t search for unicorns. You breed them,” Velis recalled one of his sons saying during a recent meeting at the Harvard Square headquarters of his new medtech-focused venture creation firm, Miraki Innovation.

    article source